Funded Tech Companies
Proniras
Proniras is a biopharmaceutical company, based in Seattle. VC investment was provided by Watson Fund, Accelerator Life Science Partners and Arch Venture Partners.
Company Overview
Company Name
Proniras
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2815 Eastlake Ave. E 300
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Website
Email Address
Company Background Information
Overview
Proniras is a specialty pharmaceutical company focused on the development of drugs for orphan neurological diseases with high unmet medical need. The Company's lead program is tezampanel, a novel AMPA/kainate receptor antagonist which antagonizes glutamate signaling in the central nervous system.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/1/2024
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thong Le
Chief Operating Officer
David Schubert
Chief Scientific Officer
Christopher Toombs
VP - Finance
Lindsay Rayle
Company Investors
- Watson Fund
- Accelerator Life Science Partners
- Arch Venture Partners
- WRF Capital
- Lilly Ventures
- WuXi AppTec
- Alexandria Venture Investments
- Johnson & Johnson Development Corporation
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs